{"entity":{"type":"insider","cik":"0001303782","url":"/insider/0001303782","json_url":"/insider/0001303782.json","name":"Javitt Jonathan C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":8,"first":"2008-08-28","last":"2024-12-18","span_basis":"filed_date"},"name_variants":[{"name":"Javitt Jonathan C","source":"filing","n_filings":8,"first_seen":"2008-08-28","last_seen":"2024-12-18"}],"transactions":[{"id":2864662,"accession":"0001415889-24-029694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-029694","line_url":"/filing/0001415889-24-029694#line-1","is_derivative":false,"issuer_cik":"0001303782","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001303782","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director, Officer (Chairman and Chief Scientist), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and Chief Scientist","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":46800.0,"total_display":"46,800.00","total_whole":"46,800","shares_owned_after":84634.0,"shares_owned_after_display":"84,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider"},{"id":8623065,"accession":"0001104659-23-094815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-094815","line_url":"/filing/0001104659-23-094815#line-1","is_derivative":false,"issuer_cik":"0001303782","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001303782","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director, Officer (Chief Scientist), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientist","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":33000.0,"total_display":"33,000.00","total_whole":"33,000","shares_owned_after":446332.0,"shares_owned_after_display":"446,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-24","scope":"insider"},{"id":8052762,"accession":"0001104659-23-094406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-094406","line_url":"/filing/0001104659-23-094406#line-1","is_derivative":false,"issuer_cik":"0001303782","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001303782","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director, Officer (Chief Scientist), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientist","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":0.322,"price_display":"0.32","price_state":"stated","total_value":64400.0,"total_display":"64,400.00","total_whole":"64,400","shares_owned_after":346332.0,"shares_owned_after_display":"346,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-23","scope":"insider"},{"id":6180111,"accession":"0001415889-22-012324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-012324","line_url":"/filing/0001415889-22-012324#line-1","is_derivative":false,"issuer_cik":"0001303782","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001303782","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":12899997.0,"shares_owned_after_display":"12,899,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-09","scope":"insider"},{"id":9208990,"accession":"0000921895-22-001874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-22-001874","line_url":"/filing/0000921895-22-001874#line-1","is_derivative":false,"issuer_cik":"0001303782","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001303782","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director, Officer (Chief Scientist), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientist","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.58,"price_display":"0.58","price_state":"stated","total_value":58000.0,"total_display":"58,000.00","total_whole":"58,000","shares_owned_after":146332.0,"shares_owned_after_display":"146,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6365075,"accession":"0000921895-22-001872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-22-001872","line_url":"/filing/0000921895-22-001872#line-1","is_derivative":false,"issuer_cik":"0001303782","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001303782","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director, Officer (Chief Scientist), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientist","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":58.0,"price_display":"58.00","price_state":"stated","total_value":5800000.0,"total_display":"5,800,000.00","total_whole":"5,800,000","shares_owned_after":146332.0,"shares_owned_after_display":"146,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":7681065,"accession":"0001144204-10-008405","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-9","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31610.0,"shares_display":"31,610","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":10115.2,"total_display":"10,115.20","total_whole":"10,115","shares_owned_after":460000.0,"shares_owned_after_display":"460,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-22","filed_date":"2010-02-16","scope":"insider"},{"id":7681063,"accession":"0001144204-10-008405","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-8","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":19200.0,"total_display":"19,200.00","total_whole":"19,200","shares_owned_after":491610.0,"shares_owned_after_display":"491,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-14","filed_date":"2010-02-16","scope":"insider"},{"id":7681061,"accession":"0001144204-10-008405","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-7","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48869.0,"shares_display":"48,869","price_per_share":0.335,"price_display":"0.34","price_state":"stated","total_value":16371.115,"total_display":"16,371.12","total_whole":"16,371","shares_owned_after":551610.0,"shares_owned_after_display":"551,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-06","filed_date":"2010-02-16","scope":"insider"},{"id":7681059,"accession":"0001144204-10-008405","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-6","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87509.0,"shares_display":"87,509","price_per_share":0.3351,"price_display":"0.34","price_state":"stated","total_value":29324.2659,"total_display":"29,324.27","total_whole":"29,324","shares_owned_after":600479.0,"shares_owned_after_display":"600,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2010-02-16","scope":"insider"},{"id":7681057,"accession":"0001144204-10-008405","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-5","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5224.0,"shares_display":"5,224","price_per_share":0.335,"price_display":"0.34","price_state":"stated","total_value":1750.04,"total_display":"1,750.04","total_whole":"1,750","shares_owned_after":687988.0,"shares_owned_after_display":"687,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-02","filed_date":"2010-02-16","scope":"insider"},{"id":7681055,"accession":"0001144204-10-008405","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-4","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":952.0,"total_display":"952.00","total_whole":"952","shares_owned_after":693212.0,"shares_owned_after_display":"693,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2010-02-16","scope":"insider"},{"id":7681053,"accession":"0001144204-10-008405","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-3","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.3152,"price_display":"0.32","price_state":"stated","total_value":15760.0,"total_display":"15,760.00","total_whole":"15,760","shares_owned_after":696012.0,"shares_owned_after_display":"696,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-30","filed_date":"2010-02-16","scope":"insider"},{"id":7681050,"accession":"0001144204-10-008405","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":213988.0,"shares_display":"213,988","price_per_share":0.3364,"price_display":"0.34","price_state":"stated","total_value":71985.5632,"total_display":"71,985.56","total_whole":"71,986","shares_owned_after":746012.0,"shares_owned_after_display":"746,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-29","filed_date":"2010-02-16","scope":"insider"},{"id":3646098,"accession":"0001181431-08-050620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-050620","line_url":"/filing/0001181431-08-050620#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":960000.0,"shares_owned_after_display":"960,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-27","filed_date":"2008-08-28","scope":"insider"},{"id":9297746,"accession":"0001144204-10-008405","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-10-008405","line_url":"/filing/0001144204-10-008405#line-10","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001303782","owner_name":"Javitt Jonathan C","owner_display_name":"Javitt Jonathan C","owner_url":"/insider/0001303782","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":960000.0,"shares_display":"960,000","price_per_share":275000.0,"price_display":"275,000.00","price_state":"stated","total_value":264000000000.0,"total_display":"264,000,000,000.00","total_whole":"264,000,000,000","shares_owned_after":960000.0,"shares_owned_after_display":"960,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-03","filed_date":"2010-02-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001719406","name":"NRX Pharmaceuticals, Inc.","url":"/issuer/0001719406","role":"Director, Officer (Chairman and Chief Scientist), Ten percent owner","n_filings":6,"first_seen":"2022-06-02","last_seen":"2024-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001137883","name":"BRAINSTORM CELL THERAPEUTICS INC","url":"/issuer/0001137883","role":"Director","n_filings":2,"first_seen":"2008-08-28","last_seen":"2010-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001303782","retrieved_at":"2026-08-23T23:43:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}